Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction

Click here to view

Additional information about the Chapter 11 reorganization and asset sales is available through Sangamo's noticing agent at https://www.veritaglobal.net/SangamoTherapeutics.

Central Nervous System

Persistent Repression of Tau in the Brain Using Engineered Zinc Finger Protein Transcription Factors
March 19th, 2021